Size frequency distributions of β-amyloid (Aβ) deposits: A comparative study of four neurodegenerative disorders

Folia Neuropathologica

Volumn 50, Issue 3, 2012, Pages 240-249

  Armstrong, Richard A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Log normal distribution; Size frequency distribution; Surface diffusion; amyloid (A )

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CORTICOBASAL DEGENERATION; DIFFUSE LEWY BODY DISEASE; DOWN SYNDROME; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PARTICLE SIZE; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

EID: 84866983763     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2012.30524     Document Type: Article

References (57)

1. Allsop D, Haga S, Ikeda SI, Mann DMA, Ishii T. Early senile deposits in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol 1989; 15: 531-542. (Pubitemid 20016994)
2. Armstrong RA. Correlations between the morphology of diffuse and primitive β-amyloid (Aβ) deposits and the frequency of associated cells in Down's syndrome. Neuropath Appl Neurobiol 1996a; 22: 527-530 (Pubitemid 27023369)
3. Armstrong RA. β-amyloid (Aβ) deposits and blood vessels: laminar distribution in the frontal cortex of patients with Alzheimer's disease. Neurosci Res Communs 1996b; 18: 19-28.
4. Armstrong RA. β-amyloid plaques: stages in life history or independent origin? Dement Geriatr Cogn Disord 1998; 9: 227-238. (Pubitemid 28279617)
5. Armstrong RA. Diffuse β-amyloid (Aβ) deposits and neurons: in situ secretion or diffusion of Aβ. Alz Rep 2001; 3: 289-294. (Pubitemid 33231068)
6. Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol 2006a; 44: 1-11.
7. Armstrong RA. Classic β-amyloid deposits cluster around large diameter bloodvessels rather than capillaries in sporadic Alzheimer's disease. Curr Neurovasc Res 2006b; 3: 289-294. (Pubitemid 44706253)
8. Armstrong RA. Size frequency distributions of abnormal protein deposits in Alzheimer's disease and variant Creutzfeldt-Jakob disease. Folia Neuropathol 2007; 45: 108-114. (Pubitemid 47520858)
9. Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease. Folia Neuropathol 2009; 7: 289-299.
10. Armstrong RA. A spatial pattern analysis of β-amyloid (Aβ) depo - sition in the temporal lobe in Alzheimer's disease. Folia Neuropathol 2010; 48: 67-74.
11. Armstrong RA. Density and spatial pattern of β-amyloid (Aβ) deposits in corticobasal degeneration. Folia Neuropathol 2011a; 49: 14-20.
12. Armstrong RA. Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease. Folia Neuropathol 2011b; 49: 153-161.
13. Armstrong RA, Hilton A. Statistical Analysis in Microbiology: Statnotes. Wiley-Blackwell, Hoboken 2011.
14. Armstrong RA, Myers D, Smith CUM. Alzheimer's disease: size class frequency distribution of senile plaques: do they indicate when a brain region was affected? Neurosci Lett 1991; 127: 223-226.
15. Armstrong RA, Smith CUM. β-amyloid (Aβ) deposition in the medial temporal lobe in Down's syndrome: effects of brain region and patient age. Neurobiol Dis 1995; 1: 139-144. (Pubitemid 124002861)
16. Armstrong RA, Myers D, Smith CUM. Factors determining the size frequency distribution of β-amyloid (Aβ) deposits in Alzheimer's disease. Exp Neurol 1997; 145: 574-579. (Pubitemid 27314808)
17. Armstrong RA, Cairns NJ, Lantos PL. Degeneration of cortical neurons associated with diffuse β-amyloid (Aβ) deposits in Alzheimer's disease. Neurosci Res Communs 1999; 24: 89-97. (Pubitemid 29201852)
18. Armstrong RA, Cairns NJ, Lantos PL. Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: Comaprison with non-demented cases and Alzheimer's disease. Dement Geriatr Cogn Disord 2000; 11: 187-192. (Pubitemid 30416022)
19. Armstrong RA, Lantos PL, Cairns NJ. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology 2008; 28: 351-365. (Pubitemid 351798982)
20. Ball M, Braak H, Coleman P, Dickson D, Duyckaerts C, Gambetti P, Hansen L, Hyman B, Jellinger K, Markesbery W, perl D, Powers J, Price J, Trojanowski JQ, Wisniewski H, Phelps C, Khachaturian Z. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S1-S2.
21. Benes FM, Reifel JL, Majocha RE, Marotta CA. Evidence for a diffusional model of Alzheimer amyloid A4 (β amyloid) during neuritic plaque formation. Neuroscience 1989; 33: 483-488. (Pubitemid 20047883)
22. Christopeit T, Hortschansky P, Schroeckh V, Guhrs K, Zandomeneghi G, Fandrich M. Mutagenic analysis of the nucleation propensity of oxidized Alzheimer's beta-amyloid peptide. Protein Sci 2005; 14: 2125-2131. (Pubitemid 41132378)
23. Cruz-Orive J. Distribution-free estimation of sphere size distribution from slabs showing overprojections and truncation, with a review of previous methods. J Microsc 1983; 131: 265-290.
24. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. Subtypes and differential laminar distribution of β/A4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases. Acta Neuropathol 1991; 81: 328-335.
25. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropath Exp Neurol 2002; 61: 935-946. (Pubitemid 35278715)
26. Gibson PH. Relationship between numbers of cortical argentophilic and congophilic senile plaques in the brains of elderly people with and without senile dementia of the Alzheimer type. Gerontology 1985; 31: 321-324. (Pubitemid 16225050)
27. Gibson PH. Ultrastructural abnormalities in the cerebral neocortex and hippocampus associated with Alzheimer's disease and aging. Acta Neuropathol 1987; 73: 86-91. (Pubitemid 17046138)
28. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122: 1131-1135. (Pubitemid 14027629)
29. Goedert M. The significance of tau and α-synuclein inclusions in neurodegenerative disease. Curr Opin in Genetics and Dev 2001; 11: 343-351. (Pubitemid 32480303)
30. Hamilton RL, Bouser R. Alzheimer's disease pathology in amylotrophic lateral sclerosis. Acta Neuropathol 2004; 107: 515-522. (Pubitemid 38765393)
31. Harper JD, Lansbury PT.Models of amyloid seeding in Alzheimer's disease and scrapie: mechanical truths and physiological consequences of time-dependent solubility of amyloid proteins. Ann Rev Biochem 1997; 66: 385-407. (Pubitemid 27274662)
32. Hyman BT, West HL, Rebeck GW, Buldyrev RN, Mantegna M, Ukleja M, Harlin S, Stanley HE. Quantitative analysis of senile plaques in Alzheimer's disease: observation of log-normal size distribu tions associated with apolipoprotein E genotype and trisomy 21 (Down's syndrome). Proc Natl Acad Sci USA 1995; 92: 3586-3590.
33. Jellinger KA, Bancher C. Neuropathology of Alzheimer's disease: a critical update. J Neural Transm 1998; 54: 77-95. (Pubitemid 28539345)
34. Kawai M, Cras P, Perry G. Serial reconstruction of β-protein amyloid plaques: relationship to microvessels and size distribution. Brain Res 1992; 592: 278-282.
35. Kuner P, Bohrmann B, Tjernberg LO, Naslund J, Huber G, Celenk S, Gruninger-Leitch F, Richards JG, Jakob-Roetne R, Kemp JA, Nordstedt C. Controlling polymerization of beta-amyloid and prion-derived protein with synthetic small molecular ligands. J Biol Chem 2000; 275: 1673-1678. (Pubitemid 30060785)
36. Li GY, Zhou P, Shao ZZ, Xie X, Chen X, Wang HH, Chunyu LJ, Yu TY. The natural silk spinning process: A nucleation-dependent aggregation mechanism. Eur J Biochem 2001; 268: 6600-6606. (Pubitemid 34014767)
37. Ma J, Yee A, Brewer B, Kayyali U, Potter H. Amyloid-associated proteins β1-antichymotrypsin and apolipoprotein e promote assembly of Alzheimer β-protein into filaments. Nature 1994; 372: 92-94.
38. Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW. Reversible in vitro growth of Alzheimer's disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 1992; 89: 5462-5466.
39. Mann DMA, Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989; 89: 169-179. (Pubitemid 19052948)
40. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovest one S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124. (Pubitemid 26374873)
41. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The consortium to establish a registry of the neuropathological assessment of Alzheimer's disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
42. Miyakawa T, Katsuragi S, Yamashita K, Ohuchi K. Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alzheimer's disease. Acta Neuropathol 1992; 83: 340-346.
43. Motte J, Williams RS. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol 1989; 77: 535-546. (Pubitemid 19095419)
44. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ. The apolipoprotein E epsilon 4 allele is associated with neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996; 47: 190-196. (Pubitemid 26243882)
45. Pollard JH. Numerical and Statistical Techniques. Cambridge University Press, Cambridge 1979, pp 97.
46. Rana AQ, Yousuf MS, Naz S, Qa'aty N. Prevalence and relation to dementia to various facators in Parkinson's disease. Psych Clin Neuro 2012; 66: 64-68.
47. Robbins EM, Betensky RA, Domnitz SB, Purcell SM, Garcia-Alloza M, Greenberg C, Rebeck GW, Hyman BT, Greenberg SM, Frosch MD, Bacskai BJ. Kinetics of capillary amyloid angiopathy progression in a transgenic mouse model of Alzheimer's disease. J Neurosci 2006; 26: 365-371. (Pubitemid 43237098)
48. Rose PE. Improved tables for the evaluation of sphere size distributions including the effect of section thickness. J Microsc 1980; 118: 135-141. (Pubitemid 10004979)
49. Saunders A, Strittmater W, Schmechel D, St. George-Hyslop P, Pericak-Vance M, Joo S, Rose B, Gasella J, Crapper-MacLachan D, Albersts M, Hulette C, Crain B, Goldgaber D, Roses A. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472. (Pubitemid 23230526)
50. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathology and clinical heterogeneity. Neurology 1997; 48: 959-969.
51. Spargo E, Luthert PJ, Anderton BH, Bruce M, Smith D, Lantos PL. Antibodies raised against different proteins of A4 protein identify a subset of plaques in Down's syndrome. Neurosci Lett 1990; 115: 345-350. (Pubitemid 20231639)
52. Stanley HE, Buldyrev SV, Cruz L, Gomez-Isla T, Havlin S, Hyman BT, Knowles R, Urbanc B, Wyart C. Statistical physics and Alzheimer's disease. Physica A 1998; 249: 460-471. (Pubitemid 128427269)
53. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 1988; 38: 359-364. (Pubitemid 18083667)
54. Urbanc B, Cruz L, Buldyrev SV, Havlin S, Irizarry MC, Stanley HE, Hyman BT. Dynamics of plaque formation in Alzheimer's disease. Biophys J 1999a; 76: 1330-1334. (Pubitemid 29262614)
55. Urbanc B, Cruz L, Buldyrev SV, Havlin S, Hyman BT, Stanley HE. Dynamic feedback in an aggregation-disaggregation model. Physic Dev E 1999b; 60: 2120-2126. (Pubitemid 129691375)
56. Weibel ER. Stereological Methods. Academic Press, London 1979, pp. 123-124.
57. Wisniewski KE, Wisniewski HM, Wen GY. Ocurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985; 17: 278-282. (Pubitemid 15136603)